top of page
Search


UroPharma is moving rapidly to commercialisation. The science and momentum are with us.
We are now moving into the MANUFACTURING STAGE, going through the pre-launch regulatory processes and distributors have been identified....

Gabriel Korn
Apr 20, 20231 min read


New opportunities in bladder treatments.
As part of UroPharma’s development, Urinary Tract Infections are a main focal point. We are please to post our joint collaboration...

Gabriel Korn
Mar 10, 20231 min read


New Bladder therapies to ease the suffering of millions by simply changing clinical practice.
UroPharma’s dtb-Instilla Intermittent will: aid the fight against anti-microbial resistance, Urinary Tract Infections and address the...

Gabriel Korn
Feb 7, 20232 min read


Benefits of Direct-to-Bladder drug targeting.
Quality of Life is a priority for healthcare professionals. Direct-to-Bladder therapies by UroPharma go a long way towards achieving best...

Gabriel Korn
Nov 25, 20221 min read
bottom of page